Ludovic Helfgott

EVP & Head of Biopharm

Mr Helfgott joined Novo Nordisk from AstraZeneca, where he was global vice president in charge of the company's Cardiovascular, Metabolism and Renal global franchise, supervising both assets in development and on the market. He joined AstraZeneca in 2005 in an international sales effectiveness role and has since held operational leadership roles...


Roles at Novo Nordisk

  • EVP & Head of Biopharm

    April 1, 2019 - present

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.